SARS-CoV-2 Virion Infectivity and Cytokine Production in Primary Human Airway Epithelial Cells

Viruses. 2022 May 2;14(5):951. doi: 10.3390/v14050951.

Abstract

The emergence of new SARS-CoV-2 variants and the replacement of preceding isolates have been observed through B.1.1.7, B.1.351, B.1.617.2, and B.1.1.529 lineages (corresponding to alpha, beta, delta, and omicron variants of concern (VoC), respectively). However, there is still a lack of biological evidence to which extent those VoC differ from the ancestral lineages. By exploiting human airway epithelial cell (HAEC) cultures, which closely resemble the human airway architecture and physiology, we report distinctive SARS-CoV-2 tropism in different respiratory tissues. In general, SARS-CoV-2 VoC predominantly infect and replicate in HAEC better than the progenitor USA-WA1 isolate or the BavPat1 isolate, which contains the D614G mutation, even though there is little to no difference between variants regarding their infectivity (i.e., virion-per-vRNA copy ratio). We also observe differential tissue-specific innate immunity activation between the upper and lower respiratory tissues in the presence of the virus. Our study provides better comprehension of the behavior of the different VoC in this physiologically relevant ex vivo model.

Keywords: SARS-CoV-2; cytokine; organotypic model; primary human airway epithelial cells; variants of concern.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / immunology
  • COVID-19* / virology
  • Cytokines* / metabolism
  • Epithelial Cells* / virology
  • Humans
  • SARS-CoV-2* / pathogenicity
  • Virion / pathogenicity

Substances

  • Cytokines

Supplementary concepts

  • SARS-CoV-2 variants

Grants and funding

This research was partially supported by the Bill & Melinda Gates Foundation (BMGF) under grant number INV-006366 and the European Health Emergency Preparedness and Response Authority (HERA). T.N.D.D received the fellowship from the European Union’s Horizon 2020 grant OrganoVIR ‘Organoids for Virus Research—An innovative training—ITN programme’. Part of this research work was performed using the ‘Caps-It’ research infrastructure (project ZW13-02) that was financially supported by the Hercules Foundation and Rega Foundation, KU Leuven.